Filing Details

Accession Number:
0001161697-25-000175
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-15 17:00:41
Reporting Period:
2025-05-13
Filing Date:
2025-05-15
Accepted Time:
2025-05-15 17:00:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1279473 Gary Ingenito 355 Alhambra Circle, Suite 801
Coral Gables FL 33134
Chief Med. & Reg. Officer No Yes No No
Transaction Summary
Sold: 244,000 shares Avg. Price: $23.67 Total Value: $5,775,720.00
Number of Shares After Transactions: 68,873 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2025-05-13 200,000 $3.42 268,873 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2025-05-13 200,000 $23.68 68,873 No 4 S Direct
Common Stock, Par Value $0.001 Per Share Acquisiton 2025-05-14 44,000 $4.64 112,873 No 4 M Direct
Common Stock, Par Value $0.001 Per Share Disposition 2025-05-14 44,000 $23.63 68,873 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options to purchase common stock Disposition 2025-05-13 200,000 $0.00 200,000 $3.42
Common Stock Options to purchase common stock Disposition 2025-05-14 44,000 $0.00 44,000 $4.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
590,282 2027-12-30 No 4 M Direct
546,282 2026-12-02 No 4 M Direct
Footnotes
  1. Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
  2. Represents a weighted average price for the shares sold. Shares were sold in a range between $23.325 and $23.93 per share.
  3. Represents a weighted average price for the shares sold. Shares were sold in a range between $23.44 and $24.025 per share.
  4. Options vested in three annual tranches beginning on December 30, 2021.
  5. Options vested in three annual tranches beginning on December 2, 2020.